Charles Mosseri - 23 Jun 2023 Form 4 Insider Report for Nuvectis Pharma, Inc. (NVCT)

Role: 10%+ Owner
Signature: /s/ Charles Mosseri-Marlio
Issuer symbol: NVCT
Transactions as of: 23 Jun 2023
Net transactions value: +$1,275,440
Form type: 4
Filing time: 26 Jun 2023, 08:45:28 UTC
Previous filing: 23 Jun 2023
Next filing: 27 Jun 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NVCT	Common Stock	Purchase	$1,275,440	+73,175	+3%	$17.43	2,511,265	23 Jun 2023	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Reflects the weighted average purchase price. The range of prices for the shares purchased was $16.9149 to $17.7559. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price.

Content

Reflects the weighted average purchase price. The range of prices for the shares purchased was $16.9149 to $17.7559. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price.